One of the most dreaded medial condition of the century is obesity. Unhealthy life style is catching up with people and is being expressed in the form of obesity. Obesity may also be caused due to medical conditions like thyroid problems. Several drugs introduced in the past to help in the weight losing process though effective caused side effects. They effects also lasted for a short period of time. Generic Acomplia is one drug that broke all conventions and is one of the most popular drugs used for losing weight. Unlike the others drugs used for similar purpose they blocked the Cannabinoid-1 (CB-1) receptors thereby cutting the signals to the brain. The craving for food is decreased due to the blocking of the receptors and this indirectly helps in reducing weight as consumption of food is lowered.
The active ingredient in the drug responsible for the blocking of the receptors is Rimonabant which is why Generic Acomplia is often referred by its generic name Rimonabant. The FDA has approved the drug to be used for reducing weight however, there are some countries which still has not approved the drug. Generic Acomplia is being promoted as Zimulti in the US. Refraining from eating unhealthy oily foods or dishes with high fat content is essential while taking the drug as proper dieting improves the results. Patient’s taking the drug must be physically active as well, if they wanted to lose their weight.
The drug initially researched for treating alcoholic and narcotic dependency became more known as a weight-losing drug because of its ability to suppress the user’s appetite. Even though the drug has gained popularity as a weight reduction drug it’s use for treating the narcotic dependency have not gone unnoticed. Generic Acomplia is yet to receive its license for treating narcotic dependency.
If you would like to make a comment, please fill out the form below.
